Get started
Author

Daniele Fagnani

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
2020 · Cristina Saura, Mafalda Oliveira, et al. · Journal of Clinical Oncology · 616
Risk factors for catheter‐related thrombosis (CRT) in cancer patients: a patient‐level data (IPD) meta‐analysis of clinical trials and prospective studies
2010 · W. SABER, T. MOUA, et al. · Journal of Thrombosis and Haemostasis · 244
PDF
Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
2018 · Mohamad Mohty, Evangelos Terpos, et al. · Clinical Lymphoma Myeloma & Leukemia · 84
D-dimer before chemotherapy might predict venous thromboembolism
2009 · Guido Arpaia, Monica Carpenedo, et al. · Blood Coagulation & Fibrinolysis · 69
Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors
2021 · Stefano Granieri, Michele Altomare, et al. · Critical Reviews in Oncology/Hematology · 41
Thrombosis-related complications and mortality in cancer patients with central venous devices: an observational study on the effect of antithrombotic prophylaxis
2006 · D. Fagnani, R. Franchi, et al. · Annals of Oncology · 28
Efficacy and safety data in elderly patients with metastatic renal cell carcinoma included in the nivolumab Expanded Access Program (EAP) in Italy
2018 · Maria Giuseppa Vitale, Sarah Scagliarini, et al. · PLoS ONE · 25
Granulocyte Colony-stimulating Factors Used in Clinical Practice: PoloNord Registry-Based Cohort Italian Study
2014 · Daniele Fagnani, Luciano Isa, et al. · Tumori Journal · 17
Second Line Therapy with Weekly Low-dose Docetaxel for Pretreated Non-Small-Cell Lung Carcinoma Patients: A Multicenter Italian Phase II Study
2004 · A. Ardizzoia, M. Acquati, et al. · Lung · 17
Rationale for Treatment and Study Design of TAILOR: A Randomized Phase III Trial of Second-line Erlotinib Versus Docetaxel in the Treatment of Patients Affected by Advanced Non–Small-Cell Lung Cancer With the Absence of Epidermal Growth Factor Receptor Mutations
2011 · Gabriella Farina, Flavia Longo, et al. · Clinical Lung Cancer · 15
Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
2015 · Monica Ganzinelli, Eliana Rulli, et al. · Scientific Reports · 14
PDF
Alpha Interferon as Initial Treatment of Essential Thrombocythemia. Analysis after Two Years of Follow-Up
1995 · Enrico Maria Pogliani, Fausto Rossini, et al. · Tumori Journal · 14
Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study
2020 · Giuseppe Procopio, Vincenzo Emanuele Chiuri, et al. · Therapeutic Advances in Medical Oncology · 10
PDF
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group
1994 · E. Bajetta, M. Di Bartolomeo, et al. · European Journal of Cancer · 10
Use of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP)
2017 · M.R. Migliorino, A. Gelibter, et al. · Annals of Oncology · 8
PDF
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study
2022 · G. Procopio, V.E. Chiuri, et al. · ESMO Open · 7
PDF
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
2021 · Beverly Moy, Mafalda Oliveira, et al. · Breast Cancer Research and Treatment · 7
PDF
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE
2020 · Daniele Santini, Saverio Cinieri, et al. · Journal of bone oncology · 7
PDF
Epirubicine-vinorelbine (EV) intravenous combination followed by oral vinorelbine (VNR) as first-line treatment in advanced breast cancer (ABC) patients: A POLONORD Group study
2005 · L. Frontini, A. Ardizzoia, et al. · Journal of Clinical Oncology · 6
Discontinuation of first-line bevacizumab in metastatic colorectal cancer: the BEAWARE Italian Observational Study
2019 · Sara Lonardi, Guglielmo Nasti, et al. · Tumori Journal · 3
The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study
2008 · Daniele Fagnani, Alessandro Bertolini, et al. · Blood Coagulation & Fibrinolysis · 3
Independent Risk Factors of Catheter-Related Thrombosis (CRT) in Adult Cancer Patients: An Individual Patient-Level Data (IPD) Meta-Analysis of Randomized Clinical Trials and Prospective Cohort Studies
2008 · Wael Saber, Teng Moua, et al. · Blood · 2
Abstract PS9-02: Neratinib + capecitabine sustains health-related quality of life (HRQoL) while improving progression-free survival (PFS) in patients with HER2+ metastatic breast cancer and ≥2 prior HER2-directed regimens
2021 · Beverly Moy, Mafalda Oliveira, et al. · Cancer Research · 1
Open-label, randomized, multicenter, phase II trial designed to compare the efficacy of CAPTEM combination versus FOLFIRI as second line treatment in patients (pts) who have progressed on or after first-line oxaliplatin-containing chemotherapy for advanced, MGMT methylated, RAS mutated colorectal cancer (CRC).
2016 · Rosa Berenato, Filippo Pietrantonio, et al. · Journal of Clinical Oncology · 1
Multicenter, prospective, case-control, observational study on the influence of venous thromboembolism on patient outcome.
2011 · M. Mandala, R. Labianca, et al. · Journal of Clinical Oncology · 1
Works count: 37
Citation count: 1,252
H-index: 12
I10-index: 14
Year
Topic
Type